TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Asian Mineral Resources Limited (“AMR” or the “Company”) (TSX-V:ASN) reminds shareholders of the Annual General and Special Meeting of Common Shareholders (the “Meeting”), which will be held on Tuesday, July 17,...Read More
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the voting results of the Company’s 2018 Annual and Special Shareholder’s Meeting (the “Meeting&#...Read More
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce results from 40 diamond drill holes (12,015 metres) as part of the 2018 exploration and definition drilling program at...Read More
TORONTO, May 28, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the Company has filed a Technical Report for its El Mochito mine in Honduras entitled, “ASC 2018 Technical Repor...Read More
TORONTO, May 14, 2018 (GLOBE NEWSWIRE) -- Asian Mineral Resources Limited (“AMR” or the “Company”) (TSX-V:ASN) is pleased to announce that it has entered into an agreement (the “Sale Agreement”) to divest its 90% ownership interest in the Ban Phuc Nickel...Read More
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2018) - Chris Buncic, CEO of Ascendant Resources Inc. talks about the company's 100 percent owned, El Mochito Mine in Honduras.If you cannot view the video above, please visit:http://www.b-tv.com/ascendant-resources-ceo-clip-90sec/ Ascendant Res...Read More
(All dollar amounts are in U.S. dollars unless otherwise specified) Q1 2018 Highlights Include: Net income of $5.29 million and earnings per share of $0.07Adjusted EBITDA of $7.95 million; third consecutive quarter of positive adjusted EBITDAFree cash flow of $5.30 million resulting in a cash ba...Read More
TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Asian Mineral Resources Limited (“AMR” or the “Company”) (TSX-V:ASN) advises shareholders that it has entered into a further loan agreement with Pala Investments Limited (“Pala”), a shareholder of AMR, to ass...Read More
TORONTO, April 20, 2018 (GLOBE NEWSWIRE) -- Asian Mineral Resources Limited (“AMR” or the “Company”) (TSX-V:ASN) wishes to announce the decision to appoint Duncan Blount as a Director, replacing Kate Southwell, who has resigned from her role as Non-Executive Directo...Read More
Record contained metal production of 21.4 million ZnEq lbs, an increase of 9% over Q4 2017 and 57% over Q1 2017ZnEq grade of 6.1%, representing an increase of 15% over 5.3% ZnEq in Q4 2017 and 9% over Q1 2017 Cash balance of US$13.1 million at March 31, 2018 vs US$8.0 million at year end 2017Qua...Read More
TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Asian Mineral Resources Limited (“AMR” or the “Company”) (TSX-V:ASN) advises shareholders that its Board of Directors (the “Board”) has continued exploring its strategic options with regard to the Ban Phuc Ni...Read More
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is very pleased to report the results of an updated Mineral Resource & Reserve Estimate for its El Mochito mine in Honduras prep...Read More
(All dollar amounts are in U.S. dollars (“$”) unless otherwise specified) Q4 2017 Highlights Positive Free Cash Flow of $0.75 million for Q4 2017 with $8.04 million in cash exiting 2017Adjusted EBITDA of $2.28 million for Q4 2017; six consecutive months of positive Adjusted EBIT...Read More
(All dollar amounts are in U.S. dollars (“$”) unless otherwise specified) Q4 2017 Highlights Positive Free Cash Flow of $0.75 million for Q4 2017 with $8.04 million in cash exiting 2017Adjusted EBITDA of $2.28 million for Q4 2017; six consecutive months of positive Adjusted EBIT...Read More
- Baseline demographics of TransCon Growth Hormone phase 3 heiGHt Trial presented - - Multiple ascending dose cohorts from TransCon PTH phase 1 clinical trial reinforced infusion-like profile over 24 hours - COPENHAGEN, Denmark, March 19, 2018 (GLOBE NEWSWIRE) -- Ascendis P...Read More
COPENHAGEN, Denmark, March 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and...Read More
TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) announced today that it plans to release its fourth quarter and year end 2017 results after the market close on Wednesday, March 21,...Read More
COPENHAGEN, Denmark, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,947,368 American Depositary Shares (“ADSs”), each of which represents one ord...Read More
COPENHAGEN, Denmark, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary Shares (“ADSs”), each of...Read More
COPENHAGEN, Denmark, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in an upc...Read More